{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T22:41:45Z","timestamp":1772232105249,"version":"3.50.1"},"update-to":[{"DOI":"10.1002\/14651858.cd005309.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2006,4,19]],"date-time":"2006-04-19T00:00:00Z","timestamp":1145404800000}}],"reference-count":73,"publisher":"Wiley","issue":"6","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd005309.pub3","type":"journal-article","created":{"date-parts":[[2006,5,9]],"date-time":"2006-05-09T20:10:34Z","timestamp":1147205434000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Fluticasone versus 'extrafine' HFA-beclomethasone dipropionate for chronic asthma in adults and children"],"prefix":"10.1002","volume":"2014","author":[{"given":"Toby J","family":"Lasserson","sequence":"first","affiliation":[{"name":"The Cochrane Collaboration; Cochrane Editorial Unit; 11-13 Cavendish Square London UK W1G 0AN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher J","family":"Cates","sequence":"additional","affiliation":[{"name":"St George's, University of London; Population Health Research Institute; Cranmer Terrace London UK SW17 0RE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma H","family":"Lasserson","sequence":"additional","affiliation":[{"name":"Stonecot Surgery; 115, Epsom Road Sutton Surrey UK SM3 9EY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"White","sequence":"additional","affiliation":[{"name":"York District Hospital; Respiratory Medicine; Wigginton Rd York North Yorks UK YO31 8HE"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,4,19]]},"reference":[{"issue":"Suppl 45","key":"10.1002\/14651858.CD005309.pub3-BIB0001|cit1","first-page":"Abstract No: P1","article-title":"Relative potency of beclomethasone propionate (BDP), delivered by HFA-MDI, and fluticasone propionate (FP) delivered by diskus [Abstract]","volume":"22","author":"Ahrens","year":"2003","journal-title":"European Respiratory Journal"},{"issue":"3","key":"10.1002\/14651858.CD005309.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1053\/rmed.2000.1025","article-title":"Efficacy of HFA-beclomethasone dipropionate extra-fine aerosol (800 microg day(-1)) versus HFA-fluticasone propionate (1000 microg day(-1)) in patients with asthma","volume":"95","author":"Aubier","year":"2001","journal-title":"Respiratory Medicine"},{"issue":"Suppl 33","key":"10.1002\/14651858.CD005309.pub3-BIB0003|cit3","first-page":"49S","article-title":"Cost-effectiveness of fluticasone compared with beclomethasone extrafine aerosol","volume":"18","author":"O'Reilly","year":"2001","journal-title":"European Respiratory Journal"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD005309.pub3-BIB0004|cit4","first-page":"A186","article-title":"Equivalence study of 800 mcg\/day HFA-BDP extrafine aerosol and 1000 mcg\/day HFA-fluticasone propionate","volume":"161","author":"Wettengel","year":"2000","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005309.pub3-BIB0005|cit5","first-page":"Abstract No: 76","article-title":"Airway systemic ratio of hydrofluoroalkane fluticasone and beclomethasone in asthmatics [Abstract]","volume":"109","author":"Currie","year":"2002","journal-title":"Journal of Allergy, Asthma and Immunolgy"},{"issue":"10","key":"10.1002\/14651858.CD005309.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/thorax.57.10.865","article-title":"Airway and systemic effects of hydrofluoroalkane fluticasone and beclomethasone in patients with asthma","volume":"57","author":"Currie","year":"2002","journal-title":"Thorax"},{"issue":"5","key":"10.1002\/14651858.CD005309.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1081-1206(10)62907-9","article-title":"A randomized, double-blind comparison of beclomethasone dipropionate extrafine aerosol and fluticasone propionate","volume":"86","author":"Fairfax","year":"2001","journal-title":"Annals of Allergy, Asthma and Immunology"},{"key":"10.1002\/14651858.CD005309.pub3-BIB0008|cit8","unstructured":"Giraud V Martinat Y Molimard M Improvement of asthma control: comparative study with beclomethasone extra fine aerosol, fluticasone or budesonide [Abstract] American Thoracic Society 100th International Conference, May 21-26 2004 A37, Poster J121"},{"issue":"6","key":"10.1002\/14651858.CD005309.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.rmed.2004.10.024","article-title":"Improvement of asthma control with beclomethasone extrafine aerosol compared to fluticasone and budesonide","volume":"99","author":"Molimard","year":"2005","journal-title":"Respiratory Medicine"},{"key":"10.1002\/14651858.CD005309.pub3-BIB0010|cit10","unstructured":"Robroeks C van de Kant K Dompeling E van Vilet D Kester A Hendriks H et al. [Abstract] Comparison of the anti inflammatory effects of extra fine HFA beclomethasone (BDP) versus fluticasone (FP)-DPI on inflammatory markers in exhaled breath in childhood asthma European Respiratory Journal 2007 385s"},{"issue":"6","key":"10.1002\/14651858.CD005309.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1081-1206(10)60052-X","article-title":"Comparison of the anti-inflammatory effects of extra-fine hydrofluoroalkane-beclomethasone versus fluticasone dry powder inhaler on exhaled inflammatory markers in childhood asthma","volume":"100","author":"Robroeks","year":"2008","journal-title":"Annals of Allergy, Asthma and Immunology"},{"issue":"4","key":"10.1002\/14651858.CD005309.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1081\/JAS-200057888","article-title":"Hydrofluoroalkane-134A beclomethasone or chlorofluorocarbon fluticasone: effect on small airways in poorly controlled asthma","volume":"42","author":"Thongngarm","year":"2005","journal-title":"Journal of Asthma"},{"issue":"3","key":"10.1002\/14651858.CD005309.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jaci.2006.11.005","article-title":"Air trapping in mild and moderate asthma: effect of inhaled corticosteroids","volume":"119","author":"Tunon-de-Lara","year":"2007","journal-title":"Journal of Allergy & Clinical Immunology"},{"key":"10.1002\/14651858.CD005309.pub3-BIB0014|cit14","unstructured":"Price D Van Aalderen WM De Baets FM Price J A double-blind comparison of fluticasone (FP) and beclomethasone extra-fine aerosol (HFA-BDP) in children with symptomatic mild to moderate asthma Allergy 2003 177"},{"issue":"Suppl 45","key":"10.1002\/14651858.CD005309.pub3-BIB0015|cit15","first-page":"Abstract no. 33","article-title":"Dose comparability of fluticasone (F) and beclomethasone extrafine aerosol (Q) in children with symptomatic asthma using dose step down study design [Abstract]","volume":"22","author":"Price","year":"2003","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD005309.pub3-BIB0016|cit16","unstructured":"Van Aalderen WMC Hugen CAC Asthma quality of life and systemic safety of beclomethasone extrafine aerosol (Q) and fluticasone in children World Allergy Organisation Congress, Vancouver, Canada, 7-12 September 2003 P 2-37"},{"issue":"7","key":"10.1002\/14651858.CD005309.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.rmed.2006.11.020","article-title":"Beclometasone dipropionate extrafine aerosol versus fluticasone propionate in children with asthma","volume":"101","author":"Aalderen","year":"2007","journal-title":"Respiratory Medicine"},{"issue":"5","key":"10.1002\/14651858.CD005309.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1046\/j.1472-8206.2003.00191.x","article-title":"Cough after inhalation of corticosteroids delivered from spacer devices in children with asthma","volume":"17","author":"Dubus","year":"2003","journal-title":"Fundamental & Clinical Pharmacology"},{"issue":"Suppl 8","key":"10.1002\/14651858.CD005309.pub3-BIB0019|cit19","first-page":"A769","article-title":"Asthma symptom control improves following switch from conventional inhaled steroid to hydrofluoroalkane beclomethasone dipropionate extrafine aerosol (HFA-BDP)","volume":"165","author":"Ederle","year":"2002","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"2","key":"10.1002\/14651858.CD005309.pub3-BIB0020|cit20","first-page":"45","article-title":"Improved control of asthma symptoms with a reduced dose of HFA-BDP extrafine aerosol: an open-label, randomised study","volume":"7","author":"Multicentre Study Group","year":"2003","journal-title":"European Review for Medical & Pharmacological Sciences"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005309.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF02500683","article-title":"Effects on bone mineral density of inhaled corticosteroids (fluticasone propionate and beclomethasone dipropionate: a two year double-blind randomised study [Abstract]","volume":"6","author":"Adams","year":"1996","journal-title":"Osteoporosis International"},{"issue":"Suppl 23","key":"10.1002\/14651858.CD005309.pub3-BIB0022|cit22","first-page":"52s","article-title":"A two-year double-blind randomised study comparing the effects of fluticasone propionate 1000 mcg\/day and beclomethasone dipropionate 2000 mcg\/day on bone mineral density and bone metabolism in asthma patients","volume":"9","author":"Egan","year":"1996","journal-title":"European Respiratory Journal"},{"issue":"6","key":"10.1002\/14651858.CD005309.pub3-BIB0023|cit23","first-page":"1267","article-title":"A randomized, double-blind study comparing the effects of beclomethasone and fluticasone on bone density over two years","volume":"13","author":"Egan","year":"1999","journal-title":"European Respiratory Journal"},{"issue":"7","key":"10.1002\/14651858.CD005309.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1136\/thorax.58.7.632","article-title":"Rapid effect of inhaled steroids on nocturnal worsening of asthma","volume":"58","author":"Frezza","year":"2003","journal-title":"Thorax"},{"issue":"Suppl 48","key":"10.1002\/14651858.CD005309.pub3-BIB0025|cit25","first-page":"378s","article-title":"The effects of fluticasone propionate\/salmeterol 50\/100ug bid in children with asthma versus beclometasone propionate 200ug BD fluticasone propionate 100ug bid dry powder inhalers [Abstract]","volume":"24","author":"Geppe","year":"2004","journal-title":"European Respiratory Journal"},{"issue":"5","key":"10.1002\/14651858.CD005309.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s001980050085","article-title":"Effect of inhaled corticosteroids on bone mineral density in childhood asthma: comparison of fluticasone propionate with beclomethasone dipropionate","volume":"8","author":"Gregson","year":"1998","journal-title":"Osteoporosis International"},{"issue":"7","key":"10.1002\/14651858.CD005309.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1080\/02770900600758465","article-title":"Usefulness of HFA-BDP for adult patients with bronchial asthma: randomized crossover study with fluticasone","volume":"43","author":"Horiguchi","year":"2006","journal-title":"Journal of Asthma"},{"issue":"Suppl 45","key":"10.1002\/14651858.CD005309.pub3-BIB0028|cit28","first-page":"Abstract No: P2","article-title":"Acceptability and efficacy of beclomethasone dipropionate (B\u00e9clojet HFA\u00ae) and fluticasone dipropionate (Flixotide HFA\u00ae, FDP) associated with the Volumatic\u00ae spacer in adults with mild to moderate persistent asthma","volume":"22","author":"Huchon","year":"2003","journal-title":"European Respiratory Journal"},{"issue":"1","key":"10.1002\/14651858.CD005309.pub3-BIB0029|cit29","first-page":"29","article-title":"Efficacy and safety of inhaled steroids in children with asthma: A comparison of fluticasone propionate with beclomethasone","volume":"6","author":"Khalilzadeh","year":"2007","journal-title":"Tanaffos"},{"issue":"Suppl 17","key":"10.1002\/14651858.CD005309.pub3-BIB0030|cit30","first-page":"257s","article-title":"Inhaled steroids in the long-term treatment of asthma: a double-blind, randomised, parallel group comparison of fluticasone propionate 500 \u00b5g daily and beclomethasone dipropionate 1000 \u00b5g daily over 12 months [Abstract]","volume":"6","author":"Kesten","year":"1993","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD005309.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0954-6111(05)80264-1","article-title":"Evaluation of fluticasone propionate (500 micrograms day-1) administered either as dry powder via a Diskhaler inhaler or pressurized inhaler and compared with beclomethasone dipropionate (1000 micrograms day-1) administered by pressurized inhaler","volume":"87","author":"Lundback","year":"1993","journal-title":"Respiratory Medicine"},{"issue":"10","key":"10.1002\/14651858.CD005309.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1164\/rccm.2105013","article-title":"Systemic effect comparisons of six inhaled corticosteroid preparations","volume":"165","author":"Martin","year":"2002","journal-title":"American Journal of Respiratory & Critical Care Medicine"},{"key":"10.1002\/14651858.CD005309.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1136\/thorax.55.5.375","article-title":"Effect of one year treatment with inhaled fluticasone propionate or beclomethasone dipropionate on bone density and bone metabolism: a randomised parallel group study in adult asthmatic subjects","volume":"55","author":"Medici","year":"2000","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD005309.pub3-BIB0034|cit34","first-page":"A407","article-title":"One-year treatment with inhaled fluticasone propionate or beclomethasone dipropionate does not affect bone density and bone metabolism. A randomised, parallel group study in adult asthmatics","volume":"157","author":"Medici","year":"1998","journal-title":"American Journal of Respiratory & Critical Care Medicine"},{"key":"10.1002\/14651858.CD005309.pub3-BIB0035|cit35","unstructured":"Migliori GB Della Bianca A Aliani M Spada E Meriggi A Bacchella L Effect of long term inhaled fluticasone propionate (FP) 250mcg bd and beclomethasone dipropionate (BDP) 500 BCG BD of marker of bone turn over in asthmatic adult patients European Respiratory Society; Oct 9-13; Madrid, Spain 1999 P3110"},{"issue":"4","key":"10.1002\/14651858.CD005309.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1365-2125.2006.02712.x","article-title":"Plasma concentrations of inhaled corticosteroids in relation to airflow obstruction in asthma","volume":"62","author":"Mortimer","year":"2006","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD005309.pub3-BIB0037|cit37","first-page":"A407","article-title":"Fluticasone propionate (FP) is more effective than higher doses of beclomethasone dipropionate (BDP) in patients with moderate asthma [Abstract]","volume":"157","author":"Murray","year":"1998","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"6","key":"10.1002\/14651858.CD005309.pub3-BIB0038|cit38","first-page":"577","article-title":"A multicenter, open-label, randomized comparison of suppressive effects on asthmatic inflammation of lower airways and improved effects on health-related QOL between HFA-BDP and fluticasone propionate","volume":"56","author":"Ohbayashi","year":"2007","journal-title":"Japanese Journal of Allergology"},{"key":"10.1002\/14651858.CD005309.pub3-BIB0039|cit39","unstructured":"Ohbayashi H Adachi M Ichinose M Ohta K Kokubu F Tamura G A multicenter open label randomized comparison of the effects of HFA-BDP and FP on asthmatic inflammation of lower airways and health related quality of life European Respiratory Journal 2007 616s"},{"key":"10.1002\/14651858.CD005309.pub3-BIB0040|cit40","unstructured":"Ohbayashi H Adachi M HFA-BDP effectively improves airway eosinophilic inflammation including the distal airways of patients with moderately severe asthma as compared with FP in a randomized open cross study [Abstract] American Thoracic Society International Conference, May 16-21 2008 A616"},{"issue":"3","key":"10.1002\/14651858.CD005309.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2332\/allergolint.O-07-522","article-title":"Hydrofluoroalkane-beclomethasone dipropionate effectively improves airway eosinophilic inflammation including the distal airways of patients with mild to moderate persistent Asthma as compared with fluticasone propionate in a randomized open double-cross study","volume":"57","author":"Ohbayashi","year":"2008","journal-title":"Allergology International"},{"issue":"1","key":"10.1002\/14651858.CD005309.pub3-BIB0042|cit42","first-page":"33","article-title":"A comparative evaluation of the efficacy of inhaled beclomethasone dipropionate budesonide and fluticasone propionate in the management of bronchial asthma","volume":"18","author":"Parakh","year":"2004","journal-title":"Indian Journal of Allergy Asthma and Immunology"},{"issue":"2","key":"10.1002\/14651858.CD005309.pub3-BIB0043|cit43","first-page":"73","article-title":"A comparative study on efficacy of inhaled fluticasone propionate and beclomethasone dipropionate in patients of bronchial asthma","volume":"18","author":"Prasad","year":"2004","journal-title":"Indian Journal of Allergy, Asthma & Immunology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD005309.pub3-BIB0044|cit44","first-page":"A185","article-title":"Cost of changing treatment with CFC-BDP ro HFA-BDP extrafine aerosol 'QVAR' in a \"Real Life\" clinical trial design over 1 year","volume":"161","author":"Price","year":"2000","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD005309.pub3-BIB0045|cit45","unstructured":"Price DB Pearson M Cresenzi K Asthma patient treatment goals and lung function - fluticasone propionate and beclomethasone dipropionate compared in a \"real-life\" trial design European Respiratory Society; Oct 9-13; Madrid, Spain 1999 P3113"},{"issue":"3","key":"10.1002\/14651858.CD005309.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1177\/147323000703500311","article-title":"Efficacy of beclomethasone dipropionate HFA 200 microg once daily in chronic obstructive pulmonary disease and bronchial asthma","volume":"35","author":"Tatsis","year":"2007","journal-title":"Journal of International Medical Research"},{"issue":"3","key":"10.1002\/14651858.CD005309.pub3-BIB0047|cit47","first-page":"86","article-title":"Quality of life assessment in asthmatic patients receiving fluticasone compare with equipotent doses of beclomethasone or budesonide","volume":"22","author":"Thomas","year":"2005","journal-title":"Lung India"},{"issue":"Suppl 50","key":"10.1002\/14651858.CD005309.pub3-BIB0048|cit48","first-page":"314s","article-title":"Incidence of oral candidiasis during treatment with fluticasone propionate versus beclomethasone dipropionate","volume":"28","author":"Todevski","year":"2006","journal-title":"European Respiratory Journal"},{"issue":"2","key":"10.1002\/14651858.CD005309.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1089\/0894268041457174","article-title":"Comparison of patient preference and ease of teaching inhaler technique for Pulmicort Turbuhaler versus pressurized metered-dose inhalers","volume":"17","author":"Welch","year":"2004","journal-title":"Journal of Aerosol Medicine"},{"issue":"5","key":"10.1002\/14651858.CD005309.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/adc.76.5.405","article-title":"Adrenal function and high dose inhaled corticosteroids for asthma","volume":"76","author":"Yiallouros","year":"1997","journal-title":"Archives of Disease in Childhood"},{"key":"10.1002\/14651858.CD005309.pub3-BIB0051|cit51","unstructured":"Zdraveska M Dimitrievska D Gjorcev A Todevski D Dokic D Incidence of oral candidiasis during treatment with fluticasone propionate versus beclomethasone dipropionate [Abstract] XIX World Allergy Organization Congress; Munich, Germany 2005 Abstract 305"},{"key":"10.1002\/14651858.CD005309.pub3-BIB0052|cit52","unstructured":"Zdraveska M Gjorcev A Dimitrievska D Todevski D Dokic D Incidence of irrative pharyngeal syndrome during treatment with fluticasone propionate versus beclomethasone dipropionate [Abstract] XIX World Allergy Organization Congress; Munich, Germany 2005 Abstract 304"},{"issue":"4","key":"10.1002\/14651858.CD005309.pub3-BIB0053|cit53","first-page":"186","article-title":"Comparison of the clinical effect of fluticasone propionate and beclomethasone dipropionate in patients with bronchial asthma","volume":"78","author":"Chlumsky","year":"1998","journal-title":"Prakticky Lekar"},{"issue":"4","key":"10.1002\/14651858.CD005309.pub3-BIB0054|cit54","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003274","article-title":"Budesonide for chronic asthma in children and adults (Cochrane review)","author":"Adams","year":"1999","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD005309.pub3-BIB0055|cit55","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002879","article-title":"Inhaled beclomethasone at different doses for chronic asthma (Cochrane review)","author":"Adams","year":"1999","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD005309.pub3-BIB0056|cit56","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002738.pub2","article-title":"Inhaled beclomethasone versus placebo for chronic asthma (Cochrane review)","author":"Adams","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD005309.pub3-BIB0057|cit57","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002310.pub4","article-title":"Fluticasone versus beclomethasone or budesonide for chronic asthma in adults and children","author":"Adams","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD005309.pub3-BIB0058|cit58","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003534.pub3","article-title":"Inhaled fluticasone at different doses for chronic asthma (Cochrane review)","author":"Adams","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD005309.pub3-BIB0059|cit59","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003135.pub4","article-title":"Inhaled fluticasone versus placebo for chronic asthma in adults and children","author":"Adams","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"Suppl B","key":"10.1002\/14651858.CD005309.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/S0954-6111(00)90153-7","article-title":"Clinical efficacy and safety of fluticasone propionate 1 mg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with severe asthma. U.K. study group","volume":"94","author":"Ayres","year":"2000","journal-title":"Respiratory Medicine"},{"key":"10.1002\/14651858.CD005309.pub3-BIB0061|cit61","unstructured":"British National Formulary http:\/\/www.bnf.org"},{"issue":"1","key":"10.1002\/14651858.CD005309.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.rmed.2004.05.015","article-title":"True device compliance: the need to consider both competence and contrivance","volume":"99","author":"Brennan","year":"2005","journal-title":"Respiratory Medicine"},{"issue":"7318","key":"10.1002\/14651858.CD005309.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1136\/bmj.323.7318.896","article-title":"Systematic review of clinical effectiveness of pressurised metered dose inhalers versus other hand held inhaler devices for delivering corticosteroids in asthma","volume":"323","author":"Brocklebank","year":"2001","journal-title":"BMJ"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD005309.pub3-BIB0064|cit64","first-page":"i1","article-title":"British Guideline on the Management of Asthma","volume":"58","author":"The British Thoracic Society\/Scottish Intercollegiate Guidelines Network","year":"2003","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD005309.pub3-BIB0065|cit65","unstructured":"Cates CJ Visual Rx. Online NNT Calculator 2003"},{"key":"10.1002\/14651858.CD005309.pub3-BIB0066|cit66","unstructured":"Global Initiative for Asthma Global Strategy for Asthma Management and Prevention NIH Publication 02-3659 2002 Available at: http:\/\/www.ginasthma.com"},{"issue":"2","key":"10.1002\/14651858.CD005309.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1378\/chest.115.2.343","article-title":"Hydrofluoroalkane-134a beclomethasone dipropionate, 400 mug, is as effective as chlorofluorocarbon beclomethasone dipropionate, 800 mug, for the treatment of moderate asthma","volume":"115","author":"Gross","year":"1999","journal-title":"Chest"},{"issue":"6","key":"10.1002\/14651858.CD005309.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1183\/09031936.98.12061346","article-title":"Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone","volume":"12","author":"Leach","year":"1998","journal-title":"European Respiratory Journal"},{"issue":"5","key":"10.1002\/14651858.CD005309.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1081-1206(10)61410-X","article-title":"Inhalation technique and variables associated with misuse of conventional metered-dose inhalers and newer dry powder inhalers in experienced adults","volume":"93","author":"Melani","year":"2004","journal-title":"Annals of Allergy Asthma & Immunology"},{"issue":"4","key":"10.1002\/14651858.CD005309.pub3-BIB0070|cit70","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004109.pub2","article-title":"High dose versus low dose inhaled corticosteroid as initial starting dose for asthma in adults and children","author":"Powell","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD005309.pub3-BIB0071|cit71","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001282","article-title":"Beclomethasone for asthma in children: effects on linear growth","author":"Sharek","year":"1999","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD005309.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.1368-5031.2004.00273.x","article-title":"The efficacy and safety of QVAR (hydrofluoroalkane-beclometasone dipropionate extrafine aerosol) in asthma (part 1): an update of clinical experience in adults","volume":"58","author":"Schayck","year":"2004","journal-title":"Interntaional Journal of Clinical Practice"},{"issue":"8","key":"10.1002\/14651858.CD005309.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1368-5031.2004.00274.x","article-title":"The efficacy and safety of QVAR (hydrofluoroalkane-beclometasone dipropionate extrafine aerosol) in asthma (Part 2): Clinical experience in children","volume":"58","author":"Schayck","year":"2004","journal-title":"International Journal of Clinical Practice"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD005309.pub3\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T15:32:01Z","timestamp":1702913521000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD005309.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Airways Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2006,4,19]]},"references-count":73,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,6]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005309.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4,19]]}}}